TXG - Chief Commercial Officer of 10x Genomics Sold $619K In Stock | Benzinga
James Wilbur, Chief Commercial Officer at 10x Genomics (NASDAQ:TXG), reported a large insider sell on November 22, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Wilbur sold 14,718 shares of 10x Genomics. The total transaction amounted to $619,493.
10x Genomics shares are trading up 3.48% at $44.3 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make an investing decision, however ...